Filing Details
- Accession Number:
- 0001628280-23-023651
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-27 18:40:19
- Reporting Period:
- 2023-06-23
- Accepted Time:
- 2023-06-27 18:40:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1437402 | Ardelyx Inc. | ARDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1815433 | Robert Blanks | C/O Ardelyx, Inc. 400 Fifth Avenue, Suite 210 Waltham MA 02451 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-06-23 | 33,333 | $3.42 | 299,467 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-23 | 33,333 | $3.63 | 266,134 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-06-23 | 33,333 | $0.00 | 33,333 | $3.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-07-18 | 2023-07-18 | No | 4 | M | Direct |
Footnotes
- This transaction relates an option that would have expired on July 18, 2023 and does not result in a reduction of shares held outright by the Reporting Person. The shares acquired upon the exercise of the option were sold pursuant to a Rule 10b5-1 stock trading plan adopted by the Reporting Person on March 24, 2023. accordingly, the Reporting Person had no discretion with regard to the timing of the transaction.
- This transaction was executed in multiple trades in prices ranging from $3.62 to $3.70, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The option, which was granted on July 18, 2013, and has an expiration date of July 18, 2023, is fully vested and exercisable.
Billionaire Hedge Funds
